Lataa...
Global Quality Statements on Reliever Use in Asthma in Adults and Children Older than 5 Years of Age
INTRODUCTION: Widespread misuse of short-acting beta-agonists (SABAs) may contribute to asthma-related morbidity and mortality. Recognizing this, the Global Initiative for Asthma neither recommends SABA monotherapy nor regards this formulation as a preferred reliever. Many health systems and healthc...
Tallennettuna:
| Julkaisussa: | Adv Ther |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Springer Healthcare
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7882466/ https://ncbi.nlm.nih.gov/pubmed/33586006 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-021-01621-0 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|